Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis pain
X Shang, Z Wang, H Tao - Therapeutics and Clinical Risk …, 2017 - Taylor & Francis
Osteoarthritis (OA) is the most common form of articular joint arthritis and a cause of
significant morbidity. In this review, we present the role of nerve growth factor (NGF) in pain …
significant morbidity. In this review, we present the role of nerve growth factor (NGF) in pain …
Control of arthritis pain with anti–nerve-growth factor: risk and benefit
MF Seidel, NE Lane - Current rheumatology reports, 2012 - Springer
Arthritis is characterized by pain and inflammation. Recently, attention has been focused on
nerve-growth factor (NGF), a neurotrophin that is a key regulator of peripheral nociception …
nerve-growth factor (NGF), a neurotrophin that is a key regulator of peripheral nociception …
[HTML][HTML] Nerve growth factor: an update on the science and therapy
MF Seidel, BL Wise, NE Lane - Osteoarthritis and cartilage, 2013 - Elsevier
Objective Nerve growth factor (NGF) is a key regulator of nociceptive pain and thus appears
to be an interesting target molecule for an innovative class of analgesic medication. We set …
to be an interesting target molecule for an innovative class of analgesic medication. We set …
The evolution of nerve growth factor inhibition in clinical medicine
BL Wise, MF Seidel, NE Lane - Nature Reviews Rheumatology, 2021 - nature.com
Nerve growth factor (NGF) is a neurotrophin that activates nociceptive neurons to transmit
pain signals from the peripheral to the central nervous system and that exerts its effects on …
pain signals from the peripheral to the central nervous system and that exerts its effects on …
[PDF][PDF] Targeting nerve growth factor to relieve pain from osteoarthritis: what can we expect?
F Berenbaum - Joint Bone Spine, 2019 - Elsevier
National and international recommendations about the management of osteoarthritis
emphasize the need for combining pharmacological and non-pharmacological treatments …
emphasize the need for combining pharmacological and non-pharmacological treatments …
Role of NGF‐TrkA signaling in calcification of articular chondrocytes
Nerve growth factor (NGF) is a key regulator of chronic osteoarthritic pain, but the exact
targets of NGF action on human articular cartilage is unknown. This study aimed to test the …
targets of NGF action on human articular cartilage is unknown. This study aimed to test the …
Nerve growth factor and pain mechanisms
Nerve growth factor (NGF) antagonism is on the verge of becoming a powerful analgesic
treatment for numerous conditions, including osteoarthritis and lower back pain. This review …
treatment for numerous conditions, including osteoarthritis and lower back pain. This review …
Selective inhibition of tropomyosin-receptor-kinase A (TrkA) reduces pain and joint damage in two rat models of inflammatory arthritis
S Ashraf, KS Bouhana, J Pheneger… - Arthritis research & …, 2016 - Springer
Background Inflammation is an essential component of arthritis pain. Nerve growth factor
(NGF) plays a key role in acute and chronic pain states especially those associated with …
(NGF) plays a key role in acute and chronic pain states especially those associated with …
Augmented pain behavioural responses to intra-articular injection of nerve growth factor in two animal models of osteoarthritis
S Ashraf, PI Mapp, J Burston, AJ Bennett… - Annals of the …, 2014 - ard.bmj.com
Objectives Nerve growth factor (NGF) is a promising analgesic target, particularly in
osteoarthritis (OA) where existing therapies are inadequate. We hypothesised that pain …
osteoarthritis (OA) where existing therapies are inadequate. We hypothesised that pain …
Anti-nerve growth factor in pain management: current evidence
DS Chang, E Hsu, DG Hottinger… - Journal of pain …, 2016 - Taylor & Francis
There continues to be an unmet need for safe and effective pain medications. Opioids and
nonsteroidal anti-inflammatory drugs (NSAIDs) dominate the clinical landscape despite …
nonsteroidal anti-inflammatory drugs (NSAIDs) dominate the clinical landscape despite …